OPRX
Health Information Services · Healthcare
Board Member
2023-10-24–present
Board Member
OptimizeRx Corp (OPRX)Equibles does not estimate personal net worth.
Get an email with a short summary when OptimizeRx Corp publishes a filing, an earnings call transcript or a press release.
Get OPRX alertsStephen L. Silvestro is recorded as Board Member at OptimizeRx Corp (OPRX) since June 20, 2025. OptimizeRx Corp reported in an 8-K filed June 24, 2025 that Stephen L. Silvestro was appointed director, effective June 20, 2025. OptimizeRx Corp reported in an 8-K filed October 25, 2023 that Stephen L. Silvestro was appointed President, effective October 24, 2023. OptimizeRx Corp reported in an 8-K filed October 16, 2023 that Stephen L. Silvestro was appointed President. The proxy statement of OptimizeRx Corp reports total compensation of $973,132 for Stephen L. Silvestro in fiscal 2024, including a base salary of $400,000. Disclosed compensation is on record for 7 fiscal years. OptimizeRx Corp is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at OptimizeRx Corp includes Stephen Silvestro (CEO and Board Member), William Febbo (CEO and Board Member), William J. Febbo (CEO and Board Member) and 7 others.
“Effective June 20, 2025, the Board increased the size of the Board to six (6) members and, upon the recommendation of the Board's Nominating & Governance Committee, appointed the Company's CEO Stephen Silvestro to serve as a director of the Company until the date of the Company's 2026 annual meeting of stockholders and until his successor is elected and qualified, except in the event of his earlier death, resignation or removal.”
“As previously disclosed, the Board determined to appoint Stephen L. Silvestro President of the Company effective as of the closing of the Merger.”
2025-06-20–present
Proxy statement
2023-10-24–present
OPRX
Health Information Services · Healthcare
Board Member
2023-10-24–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | OptimizeRx Corp (OPRX) | President, Former Chief Commercial Officer | $400,000 | $973,132 |
| 2023 | OptimizeRx Corp (OPRX) | President, Former Chief Commercial Officer | $384,583 | $970,357 |
| 2022 | OptimizeRx Corp (OPRX) | Chief Commercial Officer | $350,000 | $1,558,637 |
| 2021 | OptimizeRx Corp (OPRX) | Chief Commercial Officer | $330,000 | $1,243,902 |
| 2020 | OptimizeRx Corp (OPRX) | Chief Commercial Officer | $300,000 | $866,190 |
| 2019 | OptimizeRx Corp (OPRX) | Chief Commercial Officer | $188,821 | $1,120,199 |
| 2018 | OptimizeRx Corp (OPRX) | Chief Commercial Officer | — | — |